Status:

COMPLETED

Renin Profiling in Selection of Initial Antihypertensive Drug

Lead Sponsor:

The Louis & Rachel Rudin Foundation

Collaborating Sponsors:

Daiichi Sankyo

Conditions:

Hypertension

Eligibility:

All Genders

40-85 years

Phase:

NA

Brief Summary

The purpose of this research study is to determine whether a simple blood test measuring a hormone called renin can better determine which first drug would be most effective in controlling blood press...

Detailed Description

Hypothesis: That antihypertensive drug selection guided by activity of the renin angiotensin system will be superior to the strategy advocated in JNC 7 in achieving blood pressure control on monothera...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Males and females, 40 to 85 years of age
  • Sustained systolic blood pressure between 140-180 mm Hg
  • Free of antihypertensive therapy at randomization for at least 4 weeks
  • Exclusion criteria:
  • Ages \<40, or \>85 years
  • Systolic blood pressure \>180 mm Hg
  • Blood pressure \>180/105 mm Hg during the washout period
  • Require antihypertensive agents for non-blood pressure indications
  • Taking clonidine
  • On a beta-blocker drug and have known or suspected coronary artery disease
  • Documented history of a heart attack, new onset of chest pain, or a coronary revascularization procedure within the past year, congestive heart failure
  • Serious intercurrent illness
  • An active ulcer
  • Have certain abnormal laboratory tests (elevated serum creatinine \>1.5 mg/dl, transaminase \> 2 times upper limit of normal or active liver disease),
  • Hypersensitivity, allergy or have an intolerance to angiotensin II receptor blockers (olmesartan), hydrochlorothiazide or amlodipine
  • Mentally or legally unable to participate
  • Have or are currently abusing alcohol, have abused drugs within the past 2 years
  • Have been in another drug study in the past month.

Exclusion

    Key Trial Info

    Start Date :

    December 1 2005

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 1 2011

    Estimated Enrollment :

    185 Patients enrolled

    Trial Details

    Trial ID

    NCT00834600

    Start Date

    December 1 2005

    End Date

    October 1 2011

    Last Update

    April 19 2012

    Active Locations (5)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (5 locations)

    1

    Lincoln Medical and Mental Health Center

    The Bronx, New York, United States, 10451

    2

    Albert Einstein College of Medicine - GCRC

    The Bronx, New York, United States, 10461

    3

    Jacobi Medical Center

    The Bronx, New York, United States, 10461

    4

    Bronx Nephrology Hypertension, PC

    The Bronx, New York, United States, 10467